Spontaneous reports of adverse drug reactions are a common source of evidence in pharmacovigilance, but as the science evolves, so do the types of data used to find and assess signals. Uppsala Monitoring Centre’s Daniele Sartori reviews how signal detection practices have changed over time. Tune in to find out: Which features of case reports are most often ... Show More
Nov 21
#41 How to use artificial intelligence in pharmacovigilance, part 2 – Niklas Norén
<p>Far from a future add-on, artificial intelligence is already embedded in the cycle of drug safety, from case processing to signal detection. Versatile generative AI models have raised the bar of possibilities but also increased the stakes. How do we use them without losing tru ... Show More
29m 9s
Oct 17
#40 How to use artificial intelligence in pharmacovigilance, part 1 – Niklas Norén
<p>Far from a future add-on, artificial intelligence is already embedded in the cycle of drug safety, from case processing to signal detection. Versatile generative AI models have raised the bar of possibilities, but they have also increased the stakes. How do we use them without ... Show More
29m 1s
Jan 2024
How Can We Reduce Unnecessary Lab Testing?
Laboratory tests provide doctors with crucial information for diagnosis, monitoring disease progression, evaluating organ function, assessing risk factors for diseases and more. Laboratory testing can be reassuring, however, it is often deemed unnecessary. In this short episode r ... Show More
15m 15s
Sep 15
AI, Polygenic Risk Scores, and Antithrombotic Therapy | JACC This Week
In this episode, Editor-in-Chief Harlan Krumholz explores the evolving landscape of cardiovascular medicine, beginning with a call for responsible stewardship of artificial intelligence. Highlights include a major registry study on percutaneous aspiration for right-sided endocard ... Show More
9m 54s
Feb 2025
If your heart stops, this smartwatch-AI can call for help
00:47 A ‘smart’ way to quickly detect cardiac arrestGoogle researchers have developed an AI for a smartwatch that will call for help if its wearer is having a cardiac arrest. Trained, in part, on data gained when patients had their hearts deliberately stopped during a medical pro ... Show More
19m 58s
Feb 2025
PTJ Author Interview: Randomized Clinical Trials and Real-World Practice
<p>In this episode of the PTJ Podcast, Editor-in-Chief Steven George, PT, PhD, FAPTA, talks with Alexander Garbin, PT, DPT, PhD, and Jennifer Stevens-Lapsley, PT, PhD, FAPTA, about their recently published companion papers, which evaluated the effectiveness of a progressive multi ... Show More
24m 12s
Jun 2020
Covid-19 update: Cardiovascular disease, testing, social distancing and shielding, and dexamethasone
Kieran Walsh, clinical director at BMJ, asks editors from BMJ Learning and BMJ Best Practice to summarise the latest clinical guidance related to covid-19. Emma Scott discusses the latest guidance on cardiovascular disease. And Matt Castleden updates us on NHS Test and Trace, shi ... Show More
11m 12s
Feb 2025
The Truth About Nutrition: How You Can Take a Science-Based Approach | Bradley Johnston PhD
<p>Misinformation in nutrition is rampant. From demonizing red meat to hyping plant-based diets, conflicting advice has left many people confused about what’s truly evidence-based. In this episode, I am joined by Dr. Bradley Johnston<strong>, </strong>an expert in evidence-based ... Show More
1h 30m
Oct 2
HRV vs. VO2 max vs. ECG: Which wearable metric ACTUALLY matters? | Prof. Malcolm Findlay
Is your smartwatch just a fun gadget, or a serious medical device?
In this episode, Jonathan Wolf is joined by Dr. Malcolm Findlay, a leading consultant cardiologist, to explore the powerful health data available on your wrist. They decode the most misunderstood metric, Heart R ... Show More
47m 29s